These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 12673208

  • 21. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
    Alas S, Ng CP, Bonavida B.
    Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
    [Abstract] [Full Text] [Related]

  • 22. A novel synthetic analogue of ω-3 17,18-epoxyeicosatetraenoic acid activates TNF receptor-1/ASK1/JNK signaling to promote apoptosis in human breast cancer cells.
    Dyari HRE, Rawling T, Chen Y, Sudarmana W, Bourget K, Dwyer JM, Allison SE, Murray M.
    FASEB J; 2017 Dec; 31(12):5246-5257. PubMed ID: 28798154
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.
    Mansouri A, Ridgway LD, Korapati AL, Zhang Q, Tian L, Wang Y, Siddik ZH, Mills GB, Claret FX.
    J Biol Chem; 2003 May 23; 278(21):19245-56. PubMed ID: 12637505
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-alpha expression.
    Wang WH, Grégori G, Hullinger RL, Andrisani OM.
    Mol Cell Biol; 2004 Dec 23; 24(23):10352-65. PubMed ID: 15542843
    [Abstract] [Full Text] [Related]

  • 28. Quantitative effects on c-Jun N-terminal protein kinase signaling determine synergistic interaction of cisplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines.
    Vasilevskaya IA, Rakitina TV, O'Dwyer PJ.
    Mol Pharmacol; 2004 Jan 23; 65(1):235-43. PubMed ID: 14722256
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway.
    Yu C, Wang S, Dent P, Grant S.
    Mol Pharmacol; 2001 Jul 23; 60(1):143-54. PubMed ID: 11408609
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W, Liao QY, Hantash FM, Sanders BG, Kline K.
    Cancer Res; 2001 Sep 01; 61(17):6569-76. PubMed ID: 11522656
    [Abstract] [Full Text] [Related]

  • 33. Involvement of p38 MAP kinase during iron chelator-mediated apoptotic cell death.
    Kim BS, Yoon KH, Oh HM, Choi EY, Kim SW, Han WC, Kim EA, Choi SC, Kim TH, Yun KJ, Kim EC, Lyou JH, Nah YH, Chung HT, Cha YN, Jun CD.
    Cell Immunol; 2002 Dec 01; 220(2):96-106. PubMed ID: 12657244
    [Abstract] [Full Text] [Related]

  • 34. Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.
    Straughn JM, Oliver PG, Zhou T, Wang W, Alvarez RD, Grizzle WE, Buchsbaum DJ.
    Gynecol Oncol; 2006 Apr 01; 101(1):46-54. PubMed ID: 16271751
    [Abstract] [Full Text] [Related]

  • 35. Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death.
    Georgakis GV, Li Y, Humphreys R, Andreeff M, O'Brien S, Younes M, Carbone A, Albert V, Younes A.
    Br J Haematol; 2005 Aug 01; 130(4):501-10. PubMed ID: 16098063
    [Abstract] [Full Text] [Related]

  • 36. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA, Vellon L, Colomer R, Lupu R.
    Int J Cancer; 2005 May 20; 115(1):19-35. PubMed ID: 15657900
    [Abstract] [Full Text] [Related]

  • 37. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release.
    Gibson EM, Henson ES, Haney N, Villanueva J, Gibson SB.
    Cancer Res; 2002 Jan 15; 62(2):488-96. PubMed ID: 11809700
    [Abstract] [Full Text] [Related]

  • 38. The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death.
    Nguyen DM, Yeow WS, Ziauddin MF, Baras A, Tsai W, Reddy RM, Chua A, Cole GW, Schrump DS.
    Cancer J; 2006 Jan 15; 12(4):257-73. PubMed ID: 16925970
    [Abstract] [Full Text] [Related]

  • 39. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
    Yoshida T, Zhang Y, Rivera Rosado LA, Zhang B.
    Mol Cancer Res; 2009 Nov 15; 7(11):1835-44. PubMed ID: 19843632
    [Abstract] [Full Text] [Related]

  • 40. Acetaminophen induces apoptosis of C6 glioma cells by activating the c-Jun NH(2)-terminal protein kinase-related cell death pathway.
    Bae MA, Pie JE, Song BJ.
    Mol Pharmacol; 2001 Oct 15; 60(4):847-56. PubMed ID: 11562448
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.